{"transactions":[{"id":700455,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:26:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":309467,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."}],"balance_after":309467,"derivative":{"underlying":"Class A Common Stock","underlying_shares":309467},"source":{"system":"sec-edgar","filing":"0001628280-26-051084","document":"wk-form4_1785443178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051084/wk-form4_1785443178.xml","form_type":"4"}},{"id":700454,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:26:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":74258,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."}],"balance_after":74258,"derivative":{"underlying":"Class A Common Stock","underlying_shares":74258},"source":{"system":"sec-edgar","filing":"0001628280-26-051084","document":"wk-form4_1785443178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051084/wk-form4_1785443178.xml","form_type":"4"}},{"id":810091,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":false,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":212949},"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810090,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":false,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":212949,"derivative":{"underlying":"Class A Common Stock","underlying_shares":212949},"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810089,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":109767,"price":6.397,"value":702179.499,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":316483,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810088,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":97015,"price":6.93,"value":672313.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":426250,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810087,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":true,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":523265,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810086,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":true,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":310316,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":1533544,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Stock Option","published_at":"2024-04-29T20:49:57.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject both to time-based and performance-based vesting criteria (the \"Founder Options\"). The performance-based vesting is tied to the achievement of four specified stock price hurdles within a five-year period, with 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $5.00, 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $7.50, 20% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $10.00 and the remaining 60% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $12.50. If any of the performance-based criteria are achieved during the five-year performance period, the awards will vest on the five-year anniversary of the grant date, subject to the Reporting Person's continued employment with Ginkgo on such anniversary."}],"balance_after":5000000,"derivative":{"exercise_price":2.5,"expiration_date":"2034-04-25","underlying":"Class A Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001127602-24-013566","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760224013566/form4.xml","form_type":"4"}},{"id":1685057,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2024-01-05T22:11:58.000Z","date":"2024-01-04","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.555,"value":155500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":3894680,"source":{"system":"sec-edgar","filing":"0001127602-24-000978","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760224000978/form4.xml","form_type":"4"}},{"id":1685056,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2024-01-05T22:11:58.000Z","date":"2024-01-03","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.544,"value":154400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":3994680,"source":{"system":"sec-edgar","filing":"0001127602-24-000978","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760224000978/form4.xml","form_type":"4"}},{"id":1700560,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-22T21:57:12.000Z","date":"2023-12-21","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.737,"value":173700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.785, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4094680,"source":{"system":"sec-edgar","filing":"0001127602-23-030394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223030394/form4.xml","form_type":"4"}},{"id":1700559,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-22T21:57:12.000Z","date":"2023-12-20","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.794,"value":179400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4194680,"source":{"system":"sec-edgar","filing":"0001127602-23-030394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223030394/form4.xml","form_type":"4"}},{"id":1708628,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-15T22:05:40.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":100980,"price":1.625,"value":164092.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4294680,"source":{"system":"sec-edgar","filing":"0001127602-23-029724","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223029724/form4.xml","form_type":"4"}},{"id":1708627,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-15T22:05:40.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":99020,"price":1.341,"value":132785.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4395660,"source":{"system":"sec-edgar","filing":"0001127602-23-029724","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223029724/form4.xml","form_type":"4"}},{"id":1717364,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-08T22:15:48.000Z","date":"2023-12-07","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.313,"value":131300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4494680,"source":{"system":"sec-edgar","filing":"0001127602-23-029166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223029166/form4.xml","form_type":"4"}},{"id":1717363,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-08T22:15:48.000Z","date":"2023-12-06","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.323,"value":132300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4594680,"source":{"system":"sec-edgar","filing":"0001127602-23-029166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223029166/form4.xml","form_type":"4"}},{"id":1724967,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-01T21:59:17.000Z","date":"2023-11-30","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.353,"value":135300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.415, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4694680,"source":{"system":"sec-edgar","filing":"0001127602-23-028616","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223028616/form4.xml","form_type":"4"}},{"id":1724966,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-12-01T21:59:17.000Z","date":"2023-11-29","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.452,"value":145200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4794680,"source":{"system":"sec-edgar","filing":"0001127602-23-028616","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223028616/form4.xml","form_type":"4"}},{"id":1729308,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-27T21:58:51.000Z","date":"2023-11-24","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.413,"value":141300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.37 to $1.455, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4894680,"source":{"system":"sec-edgar","filing":"0001127602-23-028307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223028307/form4.xml","form_type":"4"}},{"id":1729307,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-27T21:58:51.000Z","date":"2023-11-22","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.404,"value":140400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.37 to $1.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4994680,"source":{"system":"sec-edgar","filing":"0001127602-23-028307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223028307/form4.xml","form_type":"4"}},{"id":1735907,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-17T21:56:04.000Z","date":"2023-11-16","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.452,"value":145200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.405 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5094680,"source":{"system":"sec-edgar","filing":"0001127602-23-027852","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223027852/form4.xml","form_type":"4"}},{"id":1735906,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-17T21:56:04.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.542,"value":154200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.445 to $1.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5194680,"source":{"system":"sec-edgar","filing":"0001127602-23-027852","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223027852/form4.xml","form_type":"4"}},{"id":1743329,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-13T13:01:37.000Z","date":"2023-11-09","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.291,"value":129100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5294680,"source":{"system":"sec-edgar","filing":"0001127602-23-027140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223027140/form4.xml","form_type":"4"}},{"id":1743328,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-13T13:01:37.000Z","date":"2023-11-08","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.502,"value":150200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5394680,"source":{"system":"sec-edgar","filing":"0001127602-23-027140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223027140/form4.xml","form_type":"4"}},{"id":1749273,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-03T21:01:07.000Z","date":"2023-11-02","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.516,"value":151600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5494680,"source":{"system":"sec-edgar","filing":"0001127602-23-026777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223026777/form4.xml","form_type":"4"}},{"id":1749272,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-11-03T21:01:07.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.342,"value":134200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.31 to $1.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5594680,"source":{"system":"sec-edgar","filing":"0001127602-23-026777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223026777/form4.xml","form_type":"4"}},{"id":1754205,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-27T20:53:51.000Z","date":"2023-10-26","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.459,"value":145900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5694680,"source":{"system":"sec-edgar","filing":"0001127602-23-026331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223026331/form4.xml","form_type":"4"}},{"id":1754204,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-27T20:53:51.000Z","date":"2023-10-25","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.476,"value":147600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.41 to $1.535 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5794680,"source":{"system":"sec-edgar","filing":"0001127602-23-026331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223026331/form4.xml","form_type":"4"}},{"id":1756774,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-20T20:54:54.000Z","date":"2023-10-19","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.606,"value":160600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.555 to $1.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5894680,"source":{"system":"sec-edgar","filing":"0001127602-23-026119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223026119/form4.xml","form_type":"4"}},{"id":1756773,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-20T20:54:54.000Z","date":"2023-10-18","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.69,"value":169000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":5994680,"source":{"system":"sec-edgar","filing":"0001127602-23-026119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223026119/form4.xml","form_type":"4"}},{"id":1760438,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-13T21:02:55.000Z","date":"2023-10-12","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.656,"value":165600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6094680,"source":{"system":"sec-edgar","filing":"0001127602-23-025844","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223025844/form4.xml","form_type":"4"}},{"id":1760437,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-13T21:02:55.000Z","date":"2023-10-11","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.756,"value":175600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.715 to $1.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6194680,"source":{"system":"sec-edgar","filing":"0001127602-23-025844","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223025844/form4.xml","form_type":"4"}},{"id":1763229,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-06T21:07:12.000Z","date":"2023-10-05","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.666,"value":166600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.615 to $1.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6294680,"source":{"system":"sec-edgar","filing":"0001127602-23-025689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223025689/form4.xml","form_type":"4"}},{"id":1763228,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-10-06T21:07:12.000Z","date":"2023-10-04","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.616,"value":161600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.56 to $1.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6394680,"source":{"system":"sec-edgar","filing":"0001127602-23-025689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223025689/form4.xml","form_type":"4"}},{"id":1771367,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-29T21:01:22.000Z","date":"2023-09-28","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.749,"value":174900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.705 to $1.795, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6494680,"source":{"system":"sec-edgar","filing":"0001127602-23-024881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223024881/form4.xml","form_type":"4"}},{"id":1771366,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-29T21:01:22.000Z","date":"2023-09-27","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.825,"value":182500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6594680,"source":{"system":"sec-edgar","filing":"0001127602-23-024881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223024881/form4.xml","form_type":"4"}},{"id":1774436,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-22T21:01:27.000Z","date":"2023-09-21","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.766,"value":176600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6694680,"source":{"system":"sec-edgar","filing":"0001127602-23-024678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223024678/form4.xml","form_type":"4"}},{"id":1774435,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-22T21:01:27.000Z","date":"2023-09-20","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.838,"value":183800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $1.885 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6794680,"source":{"system":"sec-edgar","filing":"0001127602-23-024678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223024678/form4.xml","form_type":"4"}},{"id":1779706,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-15T20:52:20.000Z","date":"2023-09-14","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.995,"value":199500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.95 to $2.075 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6894680,"source":{"system":"sec-edgar","filing":"0001127602-23-024231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223024231/form4.xml","form_type":"4"}},{"id":1779705,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-15T20:52:20.000Z","date":"2023-09-13","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.043,"value":204300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6994680,"source":{"system":"sec-edgar","filing":"0001127602-23-024231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223024231/form4.xml","form_type":"4"}},{"id":1784403,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-08T21:01:00.000Z","date":"2023-09-07","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.133,"value":213300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7094680,"source":{"system":"sec-edgar","filing":"0001127602-23-023917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223023917/form4.xml","form_type":"4"}},{"id":1784402,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-08T21:01:00.000Z","date":"2023-09-06","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.229,"value":222900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.185 to $2.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7194680,"source":{"system":"sec-edgar","filing":"0001127602-23-023917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223023917/form4.xml","form_type":"4"}},{"id":1790412,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-01T20:43:54.000Z","date":"2023-08-31","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.292,"value":229200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.235 to $2.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7294680,"source":{"system":"sec-edgar","filing":"0001127602-23-023598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223023598/form4.xml","form_type":"4"}},{"id":1790411,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-09-01T20:43:54.000Z","date":"2023-08-30","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.215,"value":221500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.12 to $2.275, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7394680,"source":{"system":"sec-edgar","filing":"0001127602-23-023598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223023598/form4.xml","form_type":"4"}},{"id":1795956,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-25T21:16:26.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.698,"value":169800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.66 to $1.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7494680,"source":{"system":"sec-edgar","filing":"0001127602-23-023257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223023257/form4.xml","form_type":"4"}},{"id":1795955,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-25T21:16:26.000Z","date":"2023-08-23","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.738,"value":173800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.66 to $1.795, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7594680,"source":{"system":"sec-edgar","filing":"0001127602-23-023257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223023257/form4.xml","form_type":"4"}},{"id":1801448,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-18T20:52:59.000Z","date":"2023-08-17","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.638,"value":163800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7694680,"source":{"system":"sec-edgar","filing":"0001127602-23-022952","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223022952/form4.xml","form_type":"4"}},{"id":1801447,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-18T20:52:59.000Z","date":"2023-08-16","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.678,"value":167800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.63 to $1.755, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7794680,"source":{"system":"sec-edgar","filing":"0001127602-23-022952","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223022952/form4.xml","form_type":"4"}},{"id":1809428,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-11T21:02:52.000Z","date":"2023-08-10","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.764,"value":176400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.705 to $1.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7894680,"source":{"system":"sec-edgar","filing":"0001127602-23-022386","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223022386/form4.xml","form_type":"4"}},{"id":1809427,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-11T21:02:52.000Z","date":"2023-08-09","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.038,"value":203800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.985 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7994680,"source":{"system":"sec-edgar","filing":"0001127602-23-022386","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223022386/form4.xml","form_type":"4"}},{"id":1814599,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-04T21:01:05.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.043,"value":204300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8094680,"source":{"system":"sec-edgar","filing":"0001127602-23-022030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223022030/form4.xml","form_type":"4"}},{"id":1814598,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-08-04T21:01:05.000Z","date":"2023-08-02","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.069,"value":206900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8194680,"source":{"system":"sec-edgar","filing":"0001127602-23-022030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223022030/form4.xml","form_type":"4"}},{"id":1821285,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-28T21:04:10.000Z","date":"2023-07-27","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.353,"value":235300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.235 to $2.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8294680,"source":{"system":"sec-edgar","filing":"0001127602-23-021533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223021533/form4.xml","form_type":"4"}},{"id":1821284,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-28T21:04:10.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.383,"value":238300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.285 to $2.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8394680,"source":{"system":"sec-edgar","filing":"0001127602-23-021533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223021533/form4.xml","form_type":"4"}},{"id":1824624,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-21T20:54:53.000Z","date":"2023-07-20","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.286,"value":228600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.215 to $2.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8494680,"source":{"system":"sec-edgar","filing":"0001127602-23-021155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223021155/form4.xml","form_type":"4"}},{"id":1824623,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-21T20:54:53.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.473,"value":247300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.37 to $2.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8594680,"source":{"system":"sec-edgar","filing":"0001127602-23-021155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223021155/form4.xml","form_type":"4"}},{"id":1829345,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-14T20:50:47.000Z","date":"2023-07-13","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.225,"value":222500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.14 to $2.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8694680,"source":{"system":"sec-edgar","filing":"0001127602-23-020733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223020733/form4.xml","form_type":"4"}},{"id":1829344,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-14T20:50:47.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":2.092,"value":209200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.005 to $2.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8794680,"source":{"system":"sec-edgar","filing":"0001127602-23-020733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223020733/form4.xml","form_type":"4"}},{"id":1832588,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-07T20:55:14.000Z","date":"2023-07-06","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.721,"value":172100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.785, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8894680,"source":{"system":"sec-edgar","filing":"0001127602-23-020472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223020472/form4.xml","form_type":"4"}},{"id":1832587,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-07-07T20:55:14.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.813,"value":181300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.76 to $1.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8994680,"source":{"system":"sec-edgar","filing":"0001127602-23-020472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223020472/form4.xml","form_type":"4"}},{"id":1840737,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-30T20:49:07.000Z","date":"2023-06-29","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.813,"value":181300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9094680,"source":{"system":"sec-edgar","filing":"0001127602-23-019640","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223019640/form4.xml","form_type":"4"}},{"id":1840736,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-30T20:49:07.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.695,"value":169500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9194680,"source":{"system":"sec-edgar","filing":"0001127602-23-019640","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223019640/form4.xml","form_type":"4"}},{"id":1844808,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-23T20:46:59.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.703,"value":170300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9294680,"source":{"system":"sec-edgar","filing":"0001127602-23-019334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223019334/form4.xml","form_type":"4"}},{"id":1844807,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-23T20:46:59.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.792,"value":179200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9394680,"source":{"system":"sec-edgar","filing":"0001127602-23-019334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223019334/form4.xml","form_type":"4"}},{"id":1851146,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-16T22:28:44.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.93,"value":193000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9494680,"source":{"system":"sec-edgar","filing":"0001127602-23-018910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223018910/form4.xml","form_type":"4"}},{"id":1851145,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-16T22:28:44.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.95,"value":195000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9594680,"source":{"system":"sec-edgar","filing":"0001127602-23-018910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223018910/form4.xml","form_type":"4"}},{"id":1859888,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-09T21:11:55.000Z","date":"2023-06-08","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.737,"value":173700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.685 to $1.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9694680,"source":{"system":"sec-edgar","filing":"0001127602-23-018446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223018446/form4.xml","form_type":"4"}},{"id":1859887,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-09T21:11:55.000Z","date":"2023-06-07","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.795,"value":179500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.745 to $1.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9794680,"source":{"system":"sec-edgar","filing":"0001127602-23-018446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223018446/form4.xml","form_type":"4"}},{"id":1868894,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-02T21:05:10.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.68,"value":168000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9894680,"source":{"system":"sec-edgar","filing":"0001127602-23-017597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223017597/form4.xml","form_type":"4"}},{"id":1868893,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-06-02T21:05:10.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.59,"value":159000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9994680,"source":{"system":"sec-edgar","filing":"0001127602-23-017597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223017597/form4.xml","form_type":"4"}},{"id":1875800,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-26T21:03:08.000Z","date":"2023-05-25","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.523,"value":152300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.485 to $1.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10094680,"source":{"system":"sec-edgar","filing":"0001127602-23-016981","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223016981/form4.xml","form_type":"4"}},{"id":1875799,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-26T21:03:08.000Z","date":"2023-05-24","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.558,"value":155800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.475 to $1.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10194680,"source":{"system":"sec-edgar","filing":"0001127602-23-016981","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223016981/form4.xml","form_type":"4"}},{"id":1883941,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-19T20:53:16.000Z","date":"2023-05-18","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.302,"value":130200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.265 to $1.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10294680,"source":{"system":"sec-edgar","filing":"0001127602-23-016332","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223016332/form4.xml","form_type":"4"}},{"id":1883940,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-19T20:53:16.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.255,"value":125500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10394680,"source":{"system":"sec-edgar","filing":"0001127602-23-016332","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223016332/form4.xml","form_type":"4"}},{"id":1894609,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-12T21:04:23.000Z","date":"2023-05-11","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.321,"value":132100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.255 to $1.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10494680,"source":{"system":"sec-edgar","filing":"0001127602-23-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223015472/form4.xml","form_type":"4"}},{"id":1894608,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-12T21:04:23.000Z","date":"2023-05-10","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.351,"value":135100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10594680,"source":{"system":"sec-edgar","filing":"0001127602-23-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223015472/form4.xml","form_type":"4"}},{"id":1902149,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-05T21:19:29.000Z","date":"2023-05-04","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.191,"value":119100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.215, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10694680,"source":{"system":"sec-edgar","filing":"0001127602-23-014765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014765/form4.xml","form_type":"4"}},{"id":1902148,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-05T21:19:29.000Z","date":"2023-05-03","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.166,"value":116600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.125 to $1.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10794680,"source":{"system":"sec-edgar","filing":"0001127602-23-014765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014765/form4.xml","form_type":"4"}},{"id":1911114,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-28T20:46:32.000Z","date":"2023-04-27","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.182,"value":118200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.16 to $1.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10894680,"source":{"system":"sec-edgar","filing":"0001127602-23-013796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223013796/form4.xml","form_type":"4"}},{"id":1911113,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-28T20:46:32.000Z","date":"2023-04-26","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.193,"value":119300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":10994680,"source":{"system":"sec-edgar","filing":"0001127602-23-013796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223013796/form4.xml","form_type":"4"}},{"id":1915418,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-21T20:46:56.000Z","date":"2023-04-20","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.284,"value":128400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.325, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11094680,"source":{"system":"sec-edgar","filing":"0001127602-23-013363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223013363/form4.xml","form_type":"4"}},{"id":1915417,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-21T20:46:56.000Z","date":"2023-04-19","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.303,"value":130300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.235 to $1.355, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11194680,"source":{"system":"sec-edgar","filing":"0001127602-23-013363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223013363/form4.xml","form_type":"4"}},{"id":1919342,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-14T20:54:34.000Z","date":"2023-04-13","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.325,"value":132500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.295 to $1.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11294680,"source":{"system":"sec-edgar","filing":"0001127602-23-012938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012938/form4.xml","form_type":"4"}},{"id":1919341,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-14T20:54:34.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.31,"value":131000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.27 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11394680,"source":{"system":"sec-edgar","filing":"0001127602-23-012938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012938/form4.xml","form_type":"4"}},{"id":1922724,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-07T20:53:59.000Z","date":"2023-04-06","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.31,"value":131000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11494680,"source":{"system":"sec-edgar","filing":"0001127602-23-012727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012727/form4.xml","form_type":"4"}},{"id":1922723,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-07T20:53:59.000Z","date":"2023-04-05","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":1.216,"value":121600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.19 to $1.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11594680,"source":{"system":"sec-edgar","filing":"0001127602-23-012727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012727/form4.xml","form_type":"4"}},{"id":1933688,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-31T21:32:27.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":1.244,"value":124400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11694680,"source":{"system":"sec-edgar","filing":"0001127602-23-011721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223011721/form4.xml","form_type":"4"}},{"id":1933687,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-31T21:32:27.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":1.235,"value":123500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.205 to $1.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11794680,"source":{"system":"sec-edgar","filing":"0001127602-23-011721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223011721/form4.xml","form_type":"4"}},{"id":1938879,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-24T21:16:39.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":1.258,"value":125800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11894680,"source":{"system":"sec-edgar","filing":"0001127602-23-011325","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223011325/form4.xml","form_type":"4"}},{"id":1938878,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-24T21:16:39.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":1.285,"value":128500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11994680,"source":{"system":"sec-edgar","filing":"0001127602-23-011325","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223011325/form4.xml","form_type":"4"}},{"id":1945539,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-17T21:02:09.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":100000,"price":1.315,"value":131500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12094680,"source":{"system":"sec-edgar","filing":"0001127602-23-010721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223010721/form4.xml","form_type":"4"}},{"id":1945538,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-17T21:02:09.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":100000,"price":1.317,"value":131700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12194680,"source":{"system":"sec-edgar","filing":"0001127602-23-010721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223010721/form4.xml","form_type":"4"}},{"id":1949446,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-16T21:29:49.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":300000,"price":1.33,"value":399000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.290 to $1.395, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12294680,"source":{"system":"sec-edgar","filing":"0001127602-23-010467","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223010467/form4.xml","form_type":"4"}},{"id":1971060,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:26:16.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":100000,"price":1.394,"value":139400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12594680,"source":{"system":"sec-edgar","filing":"0001127602-23-008818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223008818/form4.xml","form_type":"4"}},{"id":1992206,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-24T22:14:08.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":100000,"price":1.605,"value":160500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.54 to $1.725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12694680,"source":{"system":"sec-edgar","filing":"0001127602-23-007100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223007100/form4.xml","form_type":"4"}},{"id":1992205,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-24T22:14:08.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":100000,"price":1.647,"value":164700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.585 to $1.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12794680,"source":{"system":"sec-edgar","filing":"0001127602-23-007100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223007100/form4.xml","form_type":"4"}},{"id":2006262,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:11:55.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":100000,"price":1.773,"value":177300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.715 to $1.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12894680,"source":{"system":"sec-edgar","filing":"0001127602-23-005898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223005898/form4.xml","form_type":"4"}},{"id":2006261,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-17T22:11:55.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":100000,"price":1.791,"value":179100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.705 to $1.845, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":12994680,"source":{"system":"sec-edgar","filing":"0001127602-23-005898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223005898/form4.xml","form_type":"4"}},{"id":2022097,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-10T21:45:09.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":100000,"price":1.813,"value":181300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":13094680,"source":{"system":"sec-edgar","filing":"0001127602-23-004493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223004493/form4.xml","form_type":"4"}}],"next_cursor":"2023-02-10T21:45:09.000000Z,2022097"}